 | |  | |  | |  | |  | |  | |  | |  |
| IJCEM Copyright © 2008-All rights reserved. Published by e-Century Publishing Corporation, Madison, WI 53711 |
Int J Clin Exp Med 2012;5(4):346-354
Original Article
Findings of multidimensional instruments for determining psychopathology in
diabetic and non-diabetic hemodialysis patients
Gülperi Çelik, Bilge Burçak Annagür, Mümtaz Yılmaz, Fatih Kara
Department Of Internal Medicine, Division of Nephrology, Faculty of Medicine, Selçuk University, Konya, Turkey; Department of
Psychiatry, Faculty of Medicine, Selçuk University, Konya, Turkey; Department of Internal Medicine, Division of Nephrology, Kütahya State
Hospital, Kütahya, Turkey; Department of Public Health, Faculty of Medicine, Selçuk University, Konya, Turkey
Received April 26, 2012; accepted July 29, 2012; Epub August 22, 2012; Published September 15, 2012
Abstract: Objective: The aim of this study was to expand the research on psychiatric complications of end-stage renal disease (ESRD),
as well as to examine the prevalence of a broad range of psychopathology in diabetic and non-diabetic hemodialysis (HD) patients.
Methods: One hundred nineteen HD patients were invited to enter the cross-sectional study. To assess quality of life, quality of sleep,
mental status and depression and anxiety symptoms, the 36-item Short Form, Pittsburgh Sleep Quality Index (PSQI), Mini-Mental State
Examination and Hospital Anxiety and Depression Scale, respectively, were used. Results: The mean age of all patients was 56.9±16.1
years; 54 (45.4%) were female. In the diabetic patients group, 84.8% of the patients had low MCS scores, and 89.2% patients had low
PCS scores; 73.9% were poor sleepers; 63.0% had cognitive decline; 62.0% patients were depressive symptoms; and 28.3%had
symptoms of anxiety. When comparing the diabetic and non-diabetic patients, the diabetic patients had lower role–emotional, sleep
duration, and sleep efficiency scores. Conclusions: Incorporating a standard assessment and, eventually, treatment of
psychopathologic symptoms into the care provided to diabetic and hemodialysis patients might improve quality of life and sleep,
depressive symptoms and, reduce mortality risk. (IJCEM1204006).
Keywords: Anxiety, depression, hemodialysis patients, diabetes mellitus, quality of sleep, quality of life
Address all correspondence to:
Dr. Bilge Burçak Annagür
Selçuk Üniversitesi, Tıp Fakültesi, Psikiyatri AD
Selçuklu, 42075 Konya, Turkey.
Tel: +90 332 332 2444019 or +90 332 2415000; Fax: +90 332 2416065
E-mail: bilgeannagur@yahoo.com
Original Article
Findings of multidimensional instruments for determining psychopathology in
diabetic and non-diabetic hemodialysis patients
Gülperi Çelik, Bilge Burçak Annagür, Mümtaz Yılmaz, Fatih Kara
Department Of Internal Medicine, Division of Nephrology, Faculty of Medicine, Selçuk University, Konya, Turkey; Department of
Psychiatry, Faculty of Medicine, Selçuk University, Konya, Turkey; Department of Internal Medicine, Division of Nephrology, Kütahya State
Hospital, Kütahya, Turkey; Department of Public Health, Faculty of Medicine, Selçuk University, Konya, Turkey
Received April 26, 2012; accepted July 29, 2012; Epub August 22, 2012; Published September 15, 2012
Abstract: Objective: The aim of this study was to expand the research on psychiatric complications of end-stage renal disease (ESRD),
as well as to examine the prevalence of a broad range of psychopathology in diabetic and non-diabetic hemodialysis (HD) patients.
Methods: One hundred nineteen HD patients were invited to enter the cross-sectional study. To assess quality of life, quality of sleep,
mental status and depression and anxiety symptoms, the 36-item Short Form, Pittsburgh Sleep Quality Index (PSQI), Mini-Mental State
Examination and Hospital Anxiety and Depression Scale, respectively, were used. Results: The mean age of all patients was 56.9±16.1
years; 54 (45.4%) were female. In the diabetic patients group, 84.8% of the patients had low MCS scores, and 89.2% patients had low
PCS scores; 73.9% were poor sleepers; 63.0% had cognitive decline; 62.0% patients were depressive symptoms; and 28.3%had
symptoms of anxiety. When comparing the diabetic and non-diabetic patients, the diabetic patients had lower role–emotional, sleep
duration, and sleep efficiency scores. Conclusions: Incorporating a standard assessment and, eventually, treatment of
psychopathologic symptoms into the care provided to diabetic and hemodialysis patients might improve quality of life and sleep,
depressive symptoms and, reduce mortality risk. (IJCEM1204006).
Keywords: Anxiety, depression, hemodialysis patients, diabetes mellitus, quality of sleep, quality of life
Address all correspondence to:
Dr. Bilge Burçak Annagür
Selçuk Üniversitesi, Tıp Fakültesi, Psikiyatri AD
Selçuklu, 42075 Konya, Turkey.
Tel: +90 332 332 2444019 or +90 332 2415000; Fax: +90 332 2416065
E-mail: bilgeannagur@yahoo.com
